Sector dividends Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.675 USD | -0.32% |
|
-9.84% | -12.70% |
| 01-08 | Wall Street Wavers Amid Trump's Defense Budget Plans, Driving Muted Premarket Action for US Equity Futures | MT |
| 01-08 | Vanda Pharmaceuticals Says FDA Rejects Hetlioz as Jet Lag Treatment | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -2.88x | - | - | - | - | 455M | |
| 0.02% | 0.04% | 45.97x | 7.26x | 10.92x | 39.12x | 40.38x | 49.27B | |
| 1.6% | 1.47% | 18.09x | 4.33x | 6.45x | 14.35x | 15.8x | 44.15B | |
| -.--% | -.--% | -27.24x | 93x | 62.44x | -30.44x | -29.42x | 34.86B | |
| -.--% | -.--% | -27.63x | 1.26x | 4.79x | -13.08x | -10.34x | 27.38B | |
| -.--% | -.--% | 33.11x | 3.07x | 6.55x | 18.16x | 22.61x | 21.21B | |
| -.--% | -.--% | 19.16x | 3.63x | 4.92x | 12.9x | 13.86x | 21.63B | |
| -.--% | -.--% | -202.83x | 24.86x | 48.32x | -195.77x | -173.36x | 13.95B | |
| -.--% | -.--% | -459.52x | 13.39x | 29.32x | 608.28x | -489.85x | 14.58B | |
| -.--% | -.--% | -13.59x | - | 170.31x | -26.56x | -13.29x | 13.61B | |
| -.--% | -.--% | 17.35x | 4.66x | 4.98x | 12.33x | 13.6x | 12.18B | |
| -.--% | -.--% | -48x | 19.01x | 11.52x | -44.97x | -43.21x | 11.47B | |
| -.--% | -.--% | -18.71x | 16.56x | 20.8x | -26.35x | -18.91x | 9.06B | |
| -.--% | -.--% | -163.4x | 20.27x | 18.85x | 330.82x | -130.32x | 7.66B | |
| -.--% | -.--% | -18.85x | 8.12x | - | -19.41x | -18.75x | 8.37B | |
| -.--% | -.--% | -10.16x | -14.07x | 92.3x | -12.43x | -12.18x | 7.9B | |
| Average | 0.11% | 0.1% | -53.70x | 14.67x | 35.18x | 44.46x | -55.56x | 18.61B | |
| Weighted average by Cap. | 0.24% | 0.23% | -31.03x | 17.80x | 27.86x | 31.12x | -31.41x |
- Stock Market
- Equities
- VNDA Stock
- Sector Vanda Pharmaceuticals Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition